image
Healthcare - Medical - Diagnostics & Research - NYSE - US
$ 127.07
-2.42 %
$ 36.5 B
Market Cap
27.27
P/E
1. INTRINSIC VALUE

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.[ Read More ]

The intrinsic value of one A stock under the base case scenario is HIDDEN Compared to the current market price of 127 USD, Agilent Technologies, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart A

image
FINANCIALS
6.83 B REVENUE
-0.22%
1.35 B OPERATING INCOME
-16.56%
1.24 B NET INCOME
-1.12%
1.77 B OPERATING CASH FLOW
35.06%
-310 M INVESTING CASH FLOW
8.28%
-930 M FINANCING CASH FLOW
32.22%
1.58 B REVENUE
0.32%
333 M OPERATING INCOME
-8.26%
282 M NET INCOME
-8.44%
452 M OPERATING CASH FLOW
35.74%
-100 M INVESTING CASH FLOW
8.26%
-246 M FINANCING CASH FLOW
15.46%
Balance Sheet Decomposition Agilent Technologies, Inc.
image
Current Assets 4.19 B
Cash & Short-Term Investments 1.59 B
Receivables 1.29 B
Other Current Assets 1.3 B
Non-Current Assets 6.58 B
Long-Term Investments 164 M
PP&E 1.42 B
Other Non-Current Assets 4.99 B
Current Liabilities 1.6 B
Accounts Payable 418 M
Short-Term Debt 0
Other Current Liabilities 1.18 B
Non-Current Liabilities 3.32 B
Long-Term Debt 2.85 B
Other Non-Current Liabilities 462 M
EFFICIENCY
Earnings Waterfall Agilent Technologies, Inc.
image
Revenue 6.83 B
Cost Of Revenue 3.37 B
Gross Profit 3.46 B
Operating Expenses 2.12 B
Operating Income 1.35 B
Other Expenses 110 M
Net Income 1.24 B
RATIOS
50.71% GROSS MARGIN
50.71%
19.76% OPERATING MARGIN
19.76%
18.15% NET MARGIN
18.15%
21.21% ROE
21.21%
11.52% ROA
11.52%
14.57% ROIC
14.57%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Agilent Technologies, Inc.
image
Net Income 1.24 B
Depreciation & Amortization 271 M
Capital Expenditures -298 M
Stock-Based Compensation 111 M
Change in Working Capital -116 M
Others 278 M
Free Cash Flow 1.47 B
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Agilent Technologies, Inc.
image
Wall Street analysts predict an average 1-year price target for A of $142 , with forecasts ranging from a low of $105 to a high of $165 .
A Lowest Price Target Wall Street Target
105 USD -17.37%
A Average Price Target Wall Street Target
142 USD 11.39%
A Highest Price Target Wall Street Target
165 USD 29.85%
4. DIVIDEND ANALYSIS
0.17% DIVIDEND YIELD
0.236 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Agilent Technologies, Inc.
image
Sold
0-3 MONTHS
2.47 M USD 2
3-6 MONTHS
2.79 M USD 2
6-9 MONTHS
9.22 M USD 4
9-12 MONTHS
12.7 M USD 4
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
1 month ago
Sep 27, 2024
Sell 7.05 K USD
MCDONNELL PADRAIG
President and CEO
- 47
150 USD
1 month ago
Sep 26, 2024
Sell 726 K USD
Grau Dominique
Senior Vice President
- 5010
145 USD
1 month ago
Sep 26, 2024
Sell 1.45 M USD
Grau Dominique
Senior Vice President
- 9990
145 USD
2 months ago
Aug 22, 2024
Sell 284 K USD
MCDONNELL PADRAIG
President and CEO
- 1958
145 USD
3 months ago
Jul 26, 2024
Sell 274 K USD
MCDONNELL PADRAIG
President and CEO
- 1958
140 USD
5 months ago
Jun 18, 2024
Sell 264 K USD
MCDONNELL PADRAIG
President and CEO
- 1958
135 USD
5 months ago
Jun 10, 2024
Sell 2 M USD
Grau Dominique
Senior Vice President
- 15000
133.2841 USD
5 months ago
Jun 03, 2024
Sell 255 K USD
MCDONNELL PADRAIG
President and CEO
- 1958
130 USD
7 months ago
Mar 25, 2024
Sell 417 K USD
Binns Philip
Senior Vice President
- 2827
147.54 USD
8 months ago
Mar 08, 2024
Sell 7.84 M USD
McMullen Michael R.
CEO and President
- 52297
150 USD
8 months ago
Mar 07, 2024
Sell 719 K USD
Gonsalves Rodney
V.P., Corporate Controller
- 4828
148.995 USD
8 months ago
Mar 05, 2024
Sell 239 K USD
FIELDS HEIDI
Director
- 1658
144.34 USD
10 months ago
Dec 27, 2023
Sell 403 K USD
Binns Philip
Senior Vice President
- 2880
139.78 USD
11 months ago
Dec 18, 2023
Sell 207 K USD
Gonsalves Rodney
V.P., Corporate Controller
- 1500
137.692 USD
11 months ago
Dec 15, 2023
Sell 3.64 M USD
Ancher-Jensen Henrik
Sr Vice President
- 26331
138.36 USD
11 months ago
Dec 13, 2023
Sell 358 K USD
McMullen Michael R.
CEO and President
- 2751
130 USD
11 months ago
Dec 07, 2023
Sell 8.12 M USD
McMullen Michael R.
CEO and President
- 62467
130 USD
1 year ago
Sep 28, 2023
Bought 0 USD
Gonsalves Rodney
V.P., Corporate Controller
+ 0
0 USD
1 year ago
Sep 28, 2023
Bought 288 USD
Gonsalves Rodney
V.P., Corporate Controller
+ 2.59
111.09 USD
1 year ago
Aug 23, 2023
Sell 416 K USD
Gonsalves Rodney
V.P., Corporate Controller
- 3500
118.776 USD
1 year ago
Jul 27, 2023
Sell 123 K USD
McMullen Michael R.
CEO and President
- 944
130 USD
1 year ago
Dec 14, 2022
Sell 4.6 M USD
Ancher-Jensen Henrik
Sr Vice President
- 29500
155.78 USD
1 year ago
Dec 13, 2022
Sell 108 K USD
MCDONNELL PADRAIG
Sr. Vice President
- 672
160 USD
1 year ago
Dec 13, 2022
Sell 637 K USD
Grau Dominique
Senior Vice President
- 4000
159.2 USD
1 year ago
Dec 06, 2022
Sell 1.98 M USD
KOH BOON HWEE
Director
- 13000
152.2071 USD
1 year ago
Nov 30, 2022
Sell 1.5 M USD
Thaysen Jacob
Sr. Vice President
- 9700
154.6301 USD
1 year ago
Dec 01, 2022
Sell 504 K USD
Thaysen Jacob
Sr. Vice President
- 3235
155.65 USD
1 year ago
Nov 23, 2022
Sell 724 K USD
Gonsalves Rodney
V.P., Corporate Controller
- 4634
156.2 USD
1 year ago
Nov 23, 2022
Sell 566 K USD
FIELDS HEIDI
Director
- 3635
155.841 USD
1 year ago
Nov 22, 2022
Sell 1.16 M USD
Tang Michael
SVP, General Counsel, and Sec.
- 7545
153.9 USD
1 year ago
Nov 22, 2022
Sell 20 M USD
McMullen Michael R.
CEO and President
- 128726
155.73 USD
1 year ago
Nov 22, 2022
Sell 421 K USD
MCDONNELL PADRAIG
Sr. Vice President
- 2746
153.21 USD
2 years ago
Nov 16, 2022
Sell 1 M USD
McMullen Michael R.
CEO and President
- 6775
148.19 USD
2 years ago
Nov 09, 2022
Sell 937 K USD
McMullen Michael R.
CEO and President
- 6775
138.31 USD
2 years ago
Nov 02, 2022
Sell 953 K USD
McMullen Michael R.
CEO and President
- 6775
140.61 USD
2 years ago
Nov 01, 2022
Sell 502 K USD
Tang Michael
SVP, General Counsel, and Sec.
- 3600
139.5 USD
2 years ago
Oct 26, 2022
Sell 911 K USD
McMullen Michael R.
CEO and President
- 6775
134.43 USD
2 years ago
Oct 19, 2022
Sell 881 K USD
McMullen Michael R.
CEO and President
- 6775
130.11 USD
2 years ago
Sep 28, 2022
Sell 258 K USD
MCDONNELL PADRAIG
Sr. Vice President
- 2103
122.89 USD
2 years ago
Sep 09, 2022
Sell 803 K USD
Thaysen Jacob
Sr. Vice President
- 5839
137.45 USD
2 years ago
Sep 08, 2022
Sell 337 K USD
MCDONNELL PADRAIG
Sr. Vice President
- 2506
134.334 USD
2 years ago
Jun 30, 2022
Sell 119 K USD
MCDONNELL PADRAIG
Sr. Vice President
- 1000
118.625 USD
2 years ago
Jun 02, 2022
Sell 749 K USD
Thaysen Jacob
Sr. Vice President
- 5879
127.433 USD
2 years ago
Mar 18, 2022
Sell 165 K USD
Tang Michael
SVP, General Counsel, and Sec.
- 1210
136.21 USD
2 years ago
Mar 04, 2022
Bought 7.75 K USD
Nelson Clark
EVP and CCO
+ 500
15.5 USD
2 years ago
Dec 29, 2021
Sell 591 K USD
Grau Dominique
Senior Vice President
- 3669
161 USD
2 years ago
Dec 20, 2021
Sell 18.4 M USD
McMullen Michael R.
CEO and President
- 123459
148.82 USD
2 years ago
Nov 30, 2021
Sell 106 K USD
Gonsalves Rodney
V.P., Corporate Controller
- 699
152.037 USD
2 years ago
Dec 02, 2021
Sell 122 K USD
Gonsalves Rodney
V.P., Corporate Controller
- 800
151.89 USD
2 years ago
Nov 30, 2021
Sell 102 K USD
Gonsalves Rodney
V.P., Corporate Controller
- 669
152.037 USD
2 years ago
Nov 19, 2021
Sell 248 K USD
MCDONNELL PADRAIG
Senior Vice President
- 1500
165 USD
3 years ago
Aug 18, 2021
Sell 1.49 M USD
Grau Dominique
Senior Vice President
- 9033
165.055 USD
3 years ago
Aug 05, 2021
Sell 1.4 M USD
Grau Dominique
Senior Vice President
- 9033
155 USD
3 years ago
Jun 17, 2021
Sell 286 K USD
Grau Dominique
Senior Vice President
- 1968
145.103 USD
3 years ago
Jun 15, 2021
Sell 519 K USD
Grau Dominique
Senior Vice President
- 3578
145.03 USD
3 years ago
Jun 16, 2021
Sell 506 K USD
Grau Dominique
Senior Vice President
- 3487
145.011 USD
3 years ago
Jun 14, 2021
Sell 6.28 M USD
Ancher-Jensen Henrik
Sr Vice President
- 43731
143.663 USD
3 years ago
Jun 10, 2021
Sell 2.33 M USD
Thaysen Jacob
Sr. Vice President
- 16289
142.9 USD
3 years ago
May 28, 2021
Sell 138 K USD
MCDONNELL PADRAIG
Sr. Vice President
- 1000
138.42 USD
3 years ago
May 27, 2021
Sell 1.83 M USD
Tang Michael
SVP, General Counsel, and Sec.
- 13465.275
136.154 USD
3 years ago
Apr 23, 2021
Sell 68.5 K USD
Tang Michael
SVP, General Counsel, and Sec.
- 500
137 USD
3 years ago
Apr 22, 2021
Sell 1.22 M USD
McMullen Michael R.
CEO and President
- 9053
135 USD
3 years ago
Apr 13, 2021
Sell 1.19 M USD
McMullen Michael R.
CEO and President
- 8966
132.5 USD
3 years ago
Apr 08, 2021
Sell 1.97 M USD
McMullen Michael R.
CEO and President
- 15095
130.26 USD
3 years ago
Mar 31, 2021
Sell 128 K USD
Raha Samraat S.
Sr. Vice President
- 1000
127.5 USD
3 years ago
Feb 22, 2021
Sell 621 K USD
Gonsalves Rodney
V.P., Corporate Controller
- 5000
124.17 USD
3 years ago
Feb 16, 2021
Sell 64.7 K USD
Tang Michael
SVP, General Counsel, and Sec.
- 500
129.31 USD
3 years ago
Feb 17, 2021
Sell 66.5 K USD
Tang Michael
SVP, General Counsel, and Sec.
- 500
133 USD
3 years ago
Feb 16, 2021
Sell 2.7 M USD
McMullen Michael R.
CEO and President
- 20766
130 USD
3 years ago
Feb 16, 2021
Sell 786 K USD
Grau Dominique
Senior Vice President
- 6041
130.143 USD
3 years ago
Feb 17, 2021
Sell 1.86 M USD
Grau Dominique
Senior Vice President
- 13745
135.11 USD
3 years ago
Feb 01, 2021
Sell 2.55 M USD
McMullen Michael R.
CEO and President
- 21212
120.26 USD
3 years ago
Feb 02, 2021
Sell 5.19 M USD
McMullen Michael R.
CEO and President
- 41978
123.737 USD
3 years ago
Jan 14, 2021
Sell 63.6 K USD
Tang Michael
SVP, General Counsel, and Sec.
- 500
127.27 USD
3 years ago
Dec 01, 2020
Sell 9.93 M USD
McMullen Michael R.
CEO and President
- 85842
115.63 USD
3 years ago
Nov 30, 2020
Sell 2.29 M USD
KOH BOON HWEE
Director
- 20000
114.51 USD
4 years ago
Nov 09, 2020
Sell 258 K USD
Tang Michael
SVP, General Counsel, and Sec.
- 2222
116.16 USD
4 years ago
Nov 05, 2020
Sell 123 K USD
Tang Michael
SVP, General Counsel, and Sec.
- 1111
111 USD
4 years ago
Nov 03, 2020
Sell 118 K USD
Tang Michael
SVP, General Counsel, and Sec.
- 1111
106.43 USD
4 years ago
Nov 04, 2020
Sell 121 K USD
Tang Michael
SVP, General Counsel, and Sec.
- 1111
108.5 USD
4 years ago
Oct 30, 2020
Sell 339 K USD
Tang Michael
SVP, General Counsel, and Sec.
- 3333
101.77 USD
4 years ago
Nov 02, 2020
Sell 115 K USD
Tang Michael
SVP, General Counsel, and Sec.
- 1111
103.52 USD
4 years ago
Dec 20, 2019
Sell 2.09 M USD
McMullen Michael R.
CEO and President
- 24636
85 USD
4 years ago
Oct 09, 2020
Sell 681 K USD
Grau Dominique
Senior Vice President
- 6485
105 USD
4 years ago
Aug 31, 2020
Sell 648 K USD
Grau Dominique
Senior Vice President
- 6485
100 USD
4 years ago
Aug 25, 2020
Sell 608 K USD
Gonsalves Rodney
V.P., Corporate Controller
- 6191
98.167 USD
4 years ago
Jul 30, 2020
Sell 6.96 M USD
McMullen Michael R.
CEO and President
- 72716
95.764 USD
4 years ago
Jun 04, 2020
Sell 946 K USD
FIELDS HEIDI
Director
- 10392
90.999 USD
4 years ago
Jun 04, 2020
Sell 946 K USD
FIELDS HEIDI
Director
- 10392
90.999 USD
4 years ago
May 27, 2020
Sell 389 K USD
Gonsalves Rodney
V.P., Corporate Controller
- 4566
85.3043 USD
4 years ago
May 26, 2020
Sell 692 K USD
Thaysen Jacob
Sr. Vice President
- 8000
86.53 USD
4 years ago
May 26, 2020
Sell 782 K USD
Grau Dominique
Senior Vice President
- 9033
86.56 USD
4 years ago
May 15, 2020
Sell 571 K USD
McMullen Michael R.
CEO and President
- 6917
82.5 USD
4 years ago
May 08, 2020
Sell 1.44 M USD
McMullen Michael R.
CEO and President
- 18018
80 USD
4 years ago
Apr 29, 2020
Sell 1.07 M USD
McMullen Michael R.
CEO and President
- 13603
78.716 USD
4 years ago
Apr 27, 2020
Sell 672 K USD
McMullen Michael R.
CEO and President
- 8814
76.195 USD
7. News
Agilent Presents Solutions Innovation Research Awards to Institut National de la Recherche Scientifique and University of Southern California Scientists SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Professor Isabelle Plante at Institut National de la Recherche Scientifique (INRS), and Professor Bangyan Stiles at the University of Southern California (USC) are recipients of an Agilent Solutions Innovation Research Award (SIRA). The honorees will receive separate awards on behalf of their institutions in recognition of their research in cell and gene therapy. Developing new cell and gene therapies. businesswire.com - 1 week ago
Agilent Expands LSAG Segment: How Should You Approach the Stock? A's expanding LSAG portfolio may bode well for the stock, despite macroeconomic risks and stretched valuation. zacks.com - 3 weeks ago
Agilent Revolutionizes HPLC with the Launch of the Agilent Infinity III LC Series SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the release of its next generation Agilent InfinityLab LC Series portfolio, which includes the 1290 Infinity III LC, 1260 Infinity III Prime LC, and 1260 Infinity III LC systems, all including the biocompatible versions. These are the first HPLC systems on the market to feature the new Agilent InfinityLab Assist Technology, offering enhanced, built-in system assistance capabilities. This technology allows. businesswire.com - 3 weeks ago
Agilent to Announce Fourth-Quarter Fiscal Year 2024 Financial Results on Nov. 25 SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent will release financial results for the fourth quarter of fiscal year 2024 on Nov. 25. businesswire.com - 1 month ago
Agilent to Host Analyst and Investor Day on Dec. 17, 2024 SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will host an Analyst and Investor Day in New York City on Tuesday, Dec. 17, at 10 a.m. ET. CEO Padraig McDonnell, CFO Bob McMahon, and other senior business leaders will present information regarding Agilent's strategy, businesses, and long-term financial outlook. The event will conclude with a Q&A session. This in-person event is by invitation only, but a live webcast will be accessible through Agilent's Investor Rel. businesswire.com - 1 month ago
H.I.G. Capital Completes the Sale of BIOVECTRA MIAMI--(BUSINESS WIRE)-- #Acquisition--H.I.G. Capital sold its portfolio company, BIOVECTRA Inc., to Agilent Technologies, Inc. (NYSE: A) for a purchase price of $925 million. businesswire.com - 1 month ago
Why Is Agilent (A) Up 1.2% Since Last Earnings Report? Agilent (A) reported earnings 30 days ago. What's next for the stock? zacks.com - 1 month ago
Agilent Completes Acquisition of BIOVECTRA SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent today announced the company has completed its acquisition of BIOVECTRA, a Canada-based contract development and manufacturing organization. businesswire.com - 1 month ago
Agilent Announces Cash Dividend of 23.6 Cents per Share SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies, Inc. (NYSE: A) today announced a quarterly dividend of 23.6 cents per share of common stock will be paid on Oct. 23, 2024, to all shareholders of record as of the close of business on Oct. 1, 2024. The timing and amounts of future dividends are subject to determination and approval by Agilent's board of directors. About Agilent Technologies Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory tec. businesswire.com - 1 month ago
Agilent Technologies Thrives From the Forever Chemicals Crackdown Agilent Technologies Inc. NYSE: A is a diversified global leader in the life sciences, diagnostics, and applied chemical markets. The company provides equipment systems, instruments, software and services that enable researchers and scientists to make breakthroughs in the medical sector and various fields. marketbeat.com - 2 months ago
Airplane engines are in short supply. The business of fixing older ones is booming Engine repair shops have swelled to a $58 billion business, according to Alton Aviation Consultancy, and are cash cow for engine makers like GE Aerospace. cnbc.com - 2 months ago
Clough Global Equity Fund Section 19(A) Notice DENVER, CO / ACCESSWIRE / August 30, 2024 / On August 30, 2024, the Clough Global Equity Fund (NYSE American:GLQ) (the "Fund"), a closed-end fund, paid a monthly distribution on its common stock of $0.0603 per share to shareholders of record at the close of business on August 16, 2024. The following table sets forth the estimated amount of the sources of distribution for purposes of Section 19 of the Investment Company Act of 1940, as amended, and the related rules adopted thereunder. accesswire.com - 2 months ago
8. Profile Summary

Agilent Technologies, Inc. A

image
COUNTRY US
INDUSTRY Medical - Diagnostics & Research
MARKET CAP $ 36.5 B
Dividend Yield 0.17%
Description Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Contact 5301 Stevens Creek Boulevard, Santa Clara, CA, 95051 https://www.agilent.com
IPO Date Nov. 18, 1999
Employees 17400
Officers Ms. Jenipher E. Dalton Senior Vice President, Chief Quality & Regulatory Officer Mr. Rodney Gonsalves Principal Accounting Officer, Vice President & Corporate Controller Mr. Jonah Kirkwood Senior Vice President Mr. Henrik Ancher-Jensen Senior Vice President and President of Order Fulfillment & Supply Chain Mr. Dominique P. Grau Senior Vice President of Human Resources & Global Communications Ms. Yvonne Mackie MD of UK & Ireland Operations and Vice President of Human Resources - Europe Mr. John Kohl Senior Vice President & Chief Information Officer Mr. Bret M. DiMarco Senior Vice President, Chief Legal Officer, & Secretary Mr. Philip Binns Senior Vice President of Agilent and President of Life Sciences & Applied Markets Group Mr. Padraig McDonnell Chief Executive Officer, President & Director